Artal Group S.A., Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 27,775,050 shares at $2.60 ($72.2M) on 2023-06-05, disclosed to the SEC on 2023-06-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CAVA | SELL | 2024-06-07 | $261.8M | — | Filing → |
| GLYC | BUY | 2023-02-23 | $711K | — | Filing → |
| SRRK | SELL | 2023-01-11 | $10K | — | Filing → |